Brought to you by 
Neose buys all of Glytec's properties from Cytel
13 Jul 1999
Executive Summary
Cytel Corp has spun off all of the intellectual property of its carbohydrate-manufacturing division Glytec to Neose for $3.5mm up front, $1.5 in escrow until the paperwork is settled, and possibly up to $1.6mm in an earn-out.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Neose buys all of Glytec's properties from Cytel
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice